The current call for a (fresh) inquiry on assisted suicide

By Nataly Papadopoulou. As a society and as individuals, we face challenges in dealing with debilitating, horrible diseases causing suffering, indignity, and loss of autonomy. With increased emphasis on individual autonomy in a clinical but also in a legal setting, some patients wish to control the end of their lives. Perhaps one of the most […]

Read More…

NICE’s wrong turns: opportunity costs and missed opportunities

By Jonathan Michaels. The National Institute for Health and Care Excellence (NICE) is consulting on its methods for health technology evaluation, seeking ‘public’ views on over two thousand pages of highly technical supporting material.  NICE was established to promote “clinical and cost-effectiveness through guidance and audit” and address ‘postcode prescribing’ and has led the world […]

Read More…

Futile treatments and the Covid-19 pandemic: An underplayed ethical issue in non-ICU wards

By Francois-Xavier Goudot and Sandrine Bretonnière. It is still too early to predict how long and how many phases we are going to experience with the Covid-19 pandemic. In the wake of 2020, the rapid and massive worldwide dissemination of the virus induced physicians, ethicists and public health authorities – each at their national level […]

Read More…

Financing the Covid-19 Health Response: Resource Allocation, Accountability & Social Bonds

By Edana Richardson & Aisling McMahon. Adequate financing of healthcare infrastructure, supplies and personnel is a crucial element of pandemic preparedness. It is key to limiting the need for healthcare rationing, to achieving global health justice and ultimately to saving lives. In a Covid-19 context, issues have arisen around public sector obligations to provide funding […]

Read More…

The COVID-19 vaccine, informed consent and the recruitment of volunteers

By Jennifer O’Neill. Last week, in an announcement which offered hope in a time of growing despondence, Pfizer declared that their COVID-19 vaccine had “outperformed expectations in the crucial phase 3 clinical trials, proving 90% effective in stopping people falling ill.”  If approved, Pfizer’s jab will be the first in a new era of vaccines. […]

Read More…

How to ethically manage the double agency of physicians during a pandemic

By Thibaud Haaser The Covid-19 constitutes a real global crisis, going beyond the sole medical dimension. Medical, socio-economic or educational issues have highlighted the need to identify specific therapeutic or preventive agents as soon as possible. The necessity to build reliable medical knowledge is part of the response to such a crisis. Although the crisis […]

Read More…

Removing the legal barriers to treating the excruciating pain of cluster headaches

By Jonathan Leighton. There is nothing worse than extreme pain and suffering. Patients experiencing unbearable pain may take their lives to escape it. The highest priority of medicine and of society in general – the issue with the most urgent call to action – is arguably to alleviate such suffering. Although the ethical framework I […]

Read More…

Why ‘gestaticide’ is morally equivalent to infanticide

By Daniel Rodger, Nicholas Colgrove, Bruce P. Blackshaw Artificial womb technology may one day permit a fetus to be surgically removed from its mother’s body and placed into an artificial environment, mimicking life in utero. Following Elizabeth Chloe Romanis, let’s call the subjects living inside artificial wombs ‘gestatelings.’ An important question that arises is how […]

Read More…